Highlights
NASDAQ: TSRO       Tesaro Inc
Last Price Today's Change   Day's Range   Trading Volume
63.50   +1.64 (2.65%)  59.77 - 66.27  3,017,688

Overview

 
Avg Volume (4 weeks):1,145,282
4 Weeks Range:59.77 - 84.57
4 Weeks Price Volatility (%):
15.04%
52 Weeks Range:59.77 - 192.94
52 Weeks Price Volatility (%):
2.80%
Average Price Target: 70.00
Price Target Upside/Downside: +6.50

Headlines



No recent Headlines for this stock.


Business Background

TESARO, Inc. is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform. Rolapitant is a potent and long-acting neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Niraparib is an orally active and potent poly (adenosine diphosphate (ADP)-ribose) polymerase inhibitor. It has various ongoing clinical trials evaluating niraparib for the treatment of ovarian or breast cancers. It has initiated a Phase I, dose escalation study for its first immuno-oncology antibody, TSR-042, which targets Programmed cell death protein 1. It has commenced pre-clinical research for its antibody candidate targeting Lymphocyte-activation gene-3 andTSR-033. It has commenced a Phase I clinical trial of TSR-042.

  Be the first to like this.
 


 

2624  4741  579  572 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GE 16.77-0.58 
 SPY 279.14-0.47 
 BAC 31.48+0.30 
 F 12.07-0.11 
 AMD 12.47+0.29 
 VXX 26.96+0.13 
 UVXY 9.43+0.09 
 GNC 5.26+1.79 
 XLF 29.33-0.04 
 GDX 23.61-0.33 
Partners & Brokers